Sat.Jan 23, 2021 - Fri.Jan 29, 2021

article thumbnail

What we’re expecting in 2021, and beyond…

pharmaphorum

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Well, it goes without saying, COVID-19 has resulted in a rapid adoption of digital technologies across all industries, most notably in healthcare. There are several important aspects to these shifts for pharma, biotech and medical device companies, so what can we expect to see over the next 12 months and beyond?

article thumbnail

eCOA tech helps trials tackle COVID-19 obstacles: IQVIA

Outsourcing Pharma

Two leaders from the clinical technology solutions company discuss how digital tools like eCOAs have been invaluable in facing pandemic-related challenges.

120
120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PMN WEBINAR: Video, Voice, and Virtual: Applying New Digital Technology to Enhance Customer Experience

Pharma Marketing Network

2020 was a year defined by unexpected challenges – and related opportunity – for pharmaceutical marketers. Some Key Discussion Topics Include: What have we learned about how to create connection within this new paradigm? Which recent innovations are poised to become the best practices that will create measurable impact in 2021? Tune in to listen to the Pharma Marketing Network and leading experts from GSK, Otsuka & Bayer as we navigate these trends and discuss what you need to know to

98
article thumbnail

Researchers identify existing drug’s potential for triple negative breast cancer

Pharma Times

Study suggests that palbociclib could be used to treat around a fifth of people with TNBC

62
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

COVID drives a customer experience shift in life sciences CRM

pharmaphorum

The future of life sciences CRM will be defined by rapid digital transformation and a focus on customer experience – and those who stick to old ways of working will be left in the dust, according to new research from Gartner. Gartner’s’ CRM market guide notes that AI, digital scalability and hyper-automation hold the keys to sales success in the post-COVID era, and they highlight the providers who are using digital transformation to find new ways of engaging customers.

article thumbnail

Veeva Systems converts to a public benefit corporation

Outsourcing Pharma

While the change signifies the life-sciences solutions firmâs commitment to help customers and patients, day-to-day functions will remain much the same.

96

More Trending

article thumbnail

Valneva completes recruitment for Phase I/II COVID-19 vaccine study

Pharma Times

Speciality vaccine company has also started production of vaccine candidate

article thumbnail

Clinical research in 2021: A new era of collaboration and innovation

pharmaphorum

The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a spirit of collaboration and innovation. Worldwide Clinical Trial’s Aman Khera gives five predictions of how clinical research could change in 2021. The pandemic has propelled the life science industry toward higher expectations for faster, more responsive and more inclusive drug development.

article thumbnail

Paradigm4, 54gene collaborate on African clinical data

Outsourcing Pharma

With fewer than 3% of analyzed genomes currently coming from Africans, the companies are looking to increase access to and understanding of patient data.

94
article thumbnail

11 Best Robinhood Alternatives To Start Investing Your Money Better

That Frugal Pharmacist

If you are using the Robinhood app for investing, you might be considering switching or just testing out something different. After all, there are many Robinhood alternatives these days, thanks to new fintech companies looking to make it easier for anyone to invest. Yet, with all the investing platforms and apps out there, which are some … 11 Best Robinhood Alternatives To Start Investing Your Money Better Read More ».

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Moderna says its COVID-19 vaccine works effectively against variants

Pharma Times

Lab tests evaluated vaccine's efficacy against UK and South African variants

article thumbnail

RedX Pharma CEO focuses on pipeline that found Lilly’s rising star

pharmaphorum

Back in 2017, the UK biotech RedX Pharma had to sell its prized asset after administrators stepped in to stave off a debt crisis, with Loxo Oncology snapping up the BTK inhibitor for $40 million. That drug, now known as LOXO-305 was one of the stars of the American Society of Haematology (ASH) conference in December, finding its way into Eli Lilly’s pipeline after the big pharma’s $8 billion takeover of Loxo.

Packaging 119
article thumbnail

Survey reveals patients’ thoughts on trial participation

Outsourcing Pharma

Conducted by SubjectWell, the survey of patients with Type 2 diabetes reveals how ethnicity and other factors play a part in trial participation tendencies.

86
article thumbnail

Women’s Personal Finance.org – Personal BIG Project Alert

That Frugal Pharmacist

What have I been up to… well… partnering with my bestie for the expanded and awesome-r Women’s Personal Finance.org! TLDR: Go to the link above to track our progress and join the email list! My life, it is so cyclical. It feels like I have nothing going on and then a tidal wave of … Women’s Personal Finance.org – Personal BIG Project Alert Read More ».

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

NICE recommends Revlimid for newly diagnosed multiple myeloma patients

Pharma Times

Cost-effectiveness agency initially turned down the drug in this setting

54
article thumbnail

The US biosimilar market: Predictions for 2021

pharmaphorum

It has been five years since the first biosimilar launched in United States market—marking the first steps in expanding access to innovative biologic-based treatments that help patients manage and treat difficult illnesses such as cancer, rheumatoid arthritis, and other life-altering diseases. As we’ve seen over those five years, biosimilars are critical in continuing to provide doctors and patients choice in their care plans as well as continuing to decrease overall healthcare costs.

article thumbnail

FDA approves injectable treatment for HIV patients

Outsourcing Pharma

The agency has given the thumbs up to ViiVâs once-a-month Cabenuva, the first FDA-approved injectable, complete regimen for adults diagnosed with HIV.

FDA 85
article thumbnail

Tapp Network and TechSoup Digital Benchmark Report Highlights Opportunities and Challenges

Mission-Driven Marketing Blog

SAN FRANCISCO – January 27, 2021 – The results of the 2020-2021 Nonprofit Digital Marketing Benchmark Report , conducted by TechSoup and Tapp Network, unveil the disruptive effects of the COVID-19 pandemic. The report details how nonprofits are struggling to refocus their outreach efforts to the new digital normal of website automation, social media, online advertising, and content marketing.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

UK will offer its genomic expertise worldwide to identify new COVID-19 variants

Pharma Times

The New Variant Assessment Platform will be led by Public Health England

52
article thumbnail

Novartis hails digital strategy as profits hold up during pandemic

pharmaphorum

Novartis has said that its investment in digital technology has helped it to ride out the worst of the pandemic, although sales of some of its newly-launched products have been affected by a fall in prescriptions and hospital visits. The big Swiss pharma still managed to grow sales in Q4 compared with the same period last year, with sales increasing a reported 3% to $12.8 billion and profits growing 2% to just over $3 billion.

Hospitals 111
article thumbnail

Radiopharmaceuticals attract increasing interest: SpectronRx

Outsourcing Pharma

While the field is decades old, according to one specialist, more and more industry professionals are noting its diagnostic and treatment potential.

55
article thumbnail

How Different Crimes Can Affect Your Nursing License in Georgia

Pharma Mirror

Navigating your way to a career in the medical field is not easy. You may have spent late nights studying for exams and long hours working in a medical institute. But, you are finally here about to get your nursing license in the state of Georgia. When applying for a nursing license or getting your old one renewed, you might face some trouble if the background check doesn’t show up clean.

52
article thumbnail

AbbVie's Rinvoq bags two new EU approvals

Pharma Times

Oral JAK inhibitor approved for psoriatic arthritis and ankylosing spondylitis

52
article thumbnail

Stress not a significant factor in migraine attacks, study finds

pharmaphorum

New findings from a digital study have challenged the belief that stress is a significant factor in triggering migraine attacks. Results came from a study by the digital health firm Curelator and the University of Calgary, who found that only 7.1% of patients had a majority of their attacks associated with increased levels of perceived stress. At the same time 76% of the total number of migraine attacks were associated with either flat or decreasing levels of perceived stress.

article thumbnail

Designated ‘Breakthrough Therapies’ draw support from Calyx

Outsourcing Pharma

The companyâs medical imaging technology and other eClinical solutions reportedly played a part in half of the treatments to receive the FDA designation.

FDA 52
article thumbnail

Co-dydramol vs co-codamol – two related opioids

Druggist

Co-codamol is one of the most popular drugs prescribed in the UK and almost the most popular prescription painkiller. Co-dydramol, on the other hand, is much less popular medicine used for the management of pain. I will highlight the main differences between both drugs and (if possible) review the effectiveness of both drugs as painkillers. Co-dydramol vs co-codamol summary of the post: Difference between co-codamol and co-dydramol (active ingredients).

52
article thumbnail

Cheap Caribbean Vacations – The Ultimate Guide

That Frugal Pharmacist

I know, we’re still mid pandemic so cheap Caribbean vacations may not be your top thought right now. It’s really hard to believe this all started about a year ago. I also know that people are starting to get seriously stir crazy. For many, a bucket list vacation is exactly what is in the books … Cheap Caribbean Vacations – The Ultimate Guide Read More ».

52
article thumbnail

GSK suffers another R&D setback, axing ulcerative colitis drug trial

pharmaphorum

GlaxoSmithKline has suffered another research setback after it axed a phase 2 trial of an anti-LAG3 drug in patients with ulcerative colitis, following a major disappointment with a key lung cancer drug last week. Development partner Immutep had been working with GSK on GSK2831781, an anti-LAG3 cell depleting monoclonal antibody, which was derived from a drug developed by the Australian biotech.

103
103
article thumbnail

Digital Health Education for Health Professionals: What are the Next Steps?

The Digital Apothecary

I have served as an academic for the past eight years as an assistant and now associate professor of pharmacy practice, and during this time, my primary concern has been getting health professionals into digital health. It goes without saying it has been an uphill battle, and only in the past 12-24 months have I finally seen significant traction, primarily due to the ongoing Covid-19 Pandemic.

article thumbnail

EU approval for Bavencio in bladder cancer

Pharma Times

Approved for the maintenance treatment of advanced urothelial carcinoma

51
article thumbnail

SSRIs and CYP Enzymes

Med Ed 101

While many who don’t understand pharmacology consider the SSRIs to be interchangeable, significant consequences can result if we don’t pay attention to the risk of drug interactions. When looking at the SSRIs and CYP enzymes, it is critical to remember which ones can interact with other medications. There is also a significant potential that it […].

40
article thumbnail

Genetic screening before prescribing could benefit millions, study finds

pharmaphorum

Four million UK patients could benefit annually from genetic testing before being prescribed common medicines, according to new research. Researchers from the University of East Anglia (UEA) in collaboration with Boots UK and Leiden University analysed 2019 NHS dispensing data across the UK. The goal was to see how many patients are started on new prescriptions each year that could be potentially optimised by genetic testing.

article thumbnail

Can you take co-codamol with naproxen and diazepam?

Druggist

Today I will review the use of three different drugs, which occasionally are prescribed at the same time or in combination with one another. This post aims to answer the following question: can you take co-codamol with naproxen and diazepam? As a part of the discussion, I will review a licensed use of each drug and reasoning for combination treatment.